Xconomy takes a look at Transparency Life Sciences
, which is trying to apply the open source development model to drug development. "[Tomasz] Sablinski hopes the population of registered users will balloon in the coming weeks, when Transparency begins reaching out to patient advocacy groups in the disease areas it’s working in: multiple sclerosis, peripheral vascular disease, and inflammatory bowel disease. 'What we’re trying to do is channel this tremendous Web energy into helping us create experiments that will answer the right questions,' Sablinski says.
to post comments)